<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Comprehensive guide to polymyalgia rheumatica (PMR) - causes, symptoms, diagnosis, and treatment of this inflammatory condition causing muscle pain and stiffness.">
    <meta name="keywords" content="polymyalgia rheumatica, PMR, muscle stiffness, inflammatory condition, shoulder pain, hip pain">
    <title>Polymyalgia Rheumatica - Inflammatory Muscle Pain | ChronicSoreness</title>
    <link rel="canonical" href="https://chronicsoreness.com/conditions/polymyalgia-rheumatica.html">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../css/styles.css">
    <meta property="og:title" content="Polymyalgia Rheumatica - Inflammatory Muscle Pain">
    <meta property="og:description" content="Expert information on polymyalgia rheumatica causes, symptoms, and treatment options.">
    <meta property="og:type" content="article">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <header class="header">
        <nav class="nav-container">
            <div class="logo">
                <a href="../index.html">
                    <span class="logo-icon">ðŸ’œ</span>
                    <span class="logo-text"><strong>Chronic</strong>Soreness</span>
                </a>
            </div>
            <button class="mobile-menu-toggle" aria-label="Toggle menu" aria-expanded="false">
                <span class="hamburger"></span>
            </button>
            <ul class="nav-menu">
                <li><a href="../conditions.html">Conditions</a></li>
                <li><a href="../treatments.html">Treatments</a></li>
                <li><a href="../medications.html">Medications</a></li>
                <li><a href="../exercise.html">Exercise</a></li>
                <li><a href="../nutrition.html">Nutrition</a></li>
                <li><a href="../mental-health.html">Mental Health</a></li>
            </ul>
        </nav>
    </header>

    <main id="main-content">
        <article class="page-header">
            <h1>Polymyalgia Rheumatica</h1>
            <p>Understanding this inflammatory condition that causes muscle pain and stiffness in older adults</p>
        </article>

        <section class="content-section">
            <div class="container">
                <h2>What Is Polymyalgia Rheumatica?</h2>
                <p>Polymyalgia rheumatica (PMR) is an inflammatory disorder that causes muscle pain and stiffness, especially in the shoulders and hips. The name comes from Greek and Latin roots meaning "pain in many muscles."<sup>1</sup></p>
                
                <p>PMR almost exclusively affects people over age 50, with the average age of onset being around 70 years. It's more common in women than men and occurs more frequently in people of Northern European descent.<sup>2</sup></p>

                <h3>Key Characteristics</h3>
                <ul>
                    <li>Rapid onset of symptoms (often within days to weeks)</li>
                    <li>Bilateral (both sides) involvement</li>
                    <li>Morning stiffness lasting more than 45 minutes</li>
                    <li>Excellent response to low-dose corticosteroids</li>
                    <li>Potential association with giant cell arteritis</li>
                </ul>

                <h2>Causes and Risk Factors</h2>
                <p>The exact cause of PMR is unknown, but it's believed to result from a combination of genetic and environmental factors that trigger abnormal immune system activity.</p>

                <h3>Potential Triggers</h3>
                <ul>
                    <li><strong>Genetic factors</strong> - Certain HLA gene variations increase susceptibility<sup>3</sup></li>
                    <li><strong>Infections</strong> - Some viral infections may trigger the condition</li>
                    <li><strong>Immune system changes</strong> - Age-related changes in immune function</li>
                    <li><strong>Environmental factors</strong> - Seasonal patterns suggest possible environmental triggers</li>
                </ul>

                <h3>Risk Factors</h3>
                <ul>
                    <li><strong>Age</strong> - Rare under age 50; risk increases with age</li>
                    <li><strong>Sex</strong> - Women are 2-3 times more likely to develop PMR</li>
                    <li><strong>Ethnicity</strong> - More common in Caucasians of Northern European descent</li>
                    <li><strong>Geographic location</strong> - Higher rates in northern latitudes</li>
                </ul>

                <h2>Symptoms</h2>
                <p>PMR symptoms typically develop quickly, sometimes overnight, and include:</p>

                <h3>Primary Symptoms</h3>
                <ul>
                    <li><strong>Shoulder pain and stiffness</strong> - Often the first symptom; affects both shoulders</li>
                    <li><strong>Hip and thigh discomfort</strong> - Pain in hips, thighs, and buttocks</li>
                    <li><strong>Neck stiffness</strong> - Upper back and neck involvement</li>
                    <li><strong>Morning stiffness</strong> - Severe stiffness lasting 45 minutes to several hours</li>
                    <li><strong>Limited range of motion</strong> - Difficulty raising arms above shoulders</li>
                </ul>

                <h3>Systemic Symptoms</h3>
                <ul>
                    <li>Fatigue and general malaise</li>
                    <li>Low-grade fever</li>
                    <li>Loss of appetite</li>
                    <li>Unintended weight loss</li>
                    <li>Depression</li>
                </ul>

                <div class="info-box warning-box">
                    <h4>Warning: Giant Cell Arteritis</h4>
                    <p>About 10-15% of people with PMR also develop giant cell arteritis (GCA), an inflammation of blood vessels that can cause vision loss if untreated. Seek immediate medical attention if you experience new headaches, scalp tenderness, jaw pain when chewing, or visual changes.</p>
                </div>

                <h2>Diagnosis</h2>
                <p>There's no single test for PMR. Diagnosis is based on symptoms, physical examination, and excluding other conditions:</p>

                <h3>Diagnostic Criteria</h3>
                <ul>
                    <li>Age 50 or older</li>
                    <li>Bilateral shoulder and/or hip pain</li>
                    <li>Morning stiffness lasting more than 45 minutes</li>
                    <li>Elevated inflammatory markers (ESR, CRP)</li>
                    <li>Rapid response to corticosteroids</li>
                    <li>Absence of other conditions that could explain symptoms</li>
                </ul>

                <h3>Tests and Imaging</h3>
                <ul>
                    <li><strong>Blood tests</strong> - ESR and CRP to check inflammation levels; CBC; liver and kidney function</li>
                    <li><strong>Rheumatoid factor and anti-CCP</strong> - Usually negative in PMR</li>
                    <li><strong>Ultrasound</strong> - May show bursitis or synovitis in shoulders and hips<sup>4</sup></li>
                    <li><strong>MRI</strong> - Can detect inflammation in joints and bursae</li>
                </ul>

                <h2>Treatment</h2>
                <p>PMR typically responds dramatically to corticosteroid treatment, often within days.</p>

                <h3>Corticosteroid Therapy</h3>
                <p>Prednisone is the mainstay of treatment:</p>
                <ul>
                    <li><strong>Initial dose</strong> - Usually 12.5-25 mg daily<sup>5</sup></li>
                    <li><strong>Rapid response</strong> - Most patients improve within 2-4 days</li>
                    <li><strong>Gradual tapering</strong> - Dose slowly reduced over 1-2 years</li>
                    <li><strong>Long-term therapy</strong> - Many patients need treatment for 2-3 years</li>
                </ul>

                <h3>Managing Corticosteroid Side Effects</h3>
                <p>Long-term steroid use requires monitoring and prevention of complications:</p>
                <ul>
                    <li><strong>Bone health</strong> - Calcium, vitamin D, and sometimes bisphosphonates for osteoporosis prevention</li>
                    <li><strong>Blood sugar monitoring</strong> - Steroids can raise glucose levels</li>
                    <li><strong>Blood pressure monitoring</strong> - Watch for hypertension</li>
                    <li><strong>Eye examinations</strong> - Screen for cataracts and glaucoma</li>
                    <li><strong>Weight management</strong> - Steroids often cause weight gain</li>
                </ul>

                <h3>Steroid-Sparing Agents</h3>
                <p>For patients who can't taper steroids or have frequent relapses:</p>
                <ul>
                    <li><strong>Methotrexate</strong> - May help reduce steroid dose</li>
                    <li><strong>Tocilizumab (Actemra)</strong> - IL-6 inhibitor showing promise in research<sup>6</sup></li>
                    <li><strong>Other biologics</strong> - Being studied in clinical trials</li>
                </ul>

                <h2>Living with PMR</h2>
                <p>Managing PMR requires a long-term approach:</p>

                <h3>Self-Care Strategies</h3>
                <ul>
                    <li><strong>Regular exercise</strong> - Low-impact activities like walking, swimming, and tai chi</li>
                    <li><strong>Healthy diet</strong> - Calcium-rich foods, vitamin D, and anti-inflammatory foods</li>
                    <li><strong>Adequate rest</strong> - Balance activity with rest periods</li>
                    <li><strong>Stress management</strong> - Relaxation techniques can help manage symptoms</li>
                </ul>

                <h3>Medical Follow-up</h3>
                <ul>
                    <li>Regular blood tests to monitor inflammation and medication effects</li>
                    <li>Bone density scans to monitor for osteoporosis</li>
                    <li>Report any new symptoms promptly, especially headaches or vision changes</li>
                    <li>Work with your doctor on steroid tapering schedule</li>
                </ul>

                <div class="info-box">
                    <h4>Prognosis</h4>
                    <p>With proper treatment, most people with PMR can expect a good outcome. The condition typically lasts 1-5 years, and many patients eventually achieve remission and can stop medication. However, relapses can occur, especially during steroid tapering. Some patients may need long-term low-dose therapy.</p>
                </div>

                <h2>References</h2>
                <ol>
                    <li>Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. <em>Lancet</em>. 2008;372(9634):234-245.</li>
                    <li>Crowson CS, Matteson EL, Myasoedova E, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. <em>Arthritis & Rheumatism</em>. 2011;63(3):633-639.</li>
                    <li>GonzÃ¡lez-Gay MA, Matteson EL, CastaÃ±eda S. Polymyalgia rheumatica. <em>Lancet</em>. 2017;390(10103):1700-1712.</li>
                    <li>Mackie SL, Koduri G, Hill CL, et al. Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. <em>RMD Open</em>. 2015;1(1):e000100.</li>
                    <li>Dejaco C, Singh YP, Perel P, et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. <em>Annals of the Rheumatic Diseases</em>. 2015;74(10):1799-1807.</li>
                    <li>Devauchelle-Pensec V, Carvajal-Alegria G, DieudÃ© P, et al. Effect of tocilizumab on disease activity in patients with polymyalgia rheumatica: the PMR-SPARE randomized clinical trial. <em>JAMA</em>. 2022;328(11):1041-1049.</li>
                </ol>
            </div>
        </section>
    </main>

    <footer class="footer">
        <div class="container">
            <div class="footer-grid">
                <div class="footer-brand">
                    <span class="logo-icon">ðŸ’œ</span>
                    <span class="logo-text"><strong>Chronic</strong>Soreness</span>
                    <p>Your trusted resource for chronic pain information and support.</p>
                </div>
                <div class="footer-links">
                    <h4>Quick Links</h4>
                    <ul>
                        <li><a href="../about.html">About Us</a></li>
                        <li><a href="../contact.html">Contact</a></li>
                        <li><a href="../privacy.html">Privacy Policy</a></li>
                        <li><a href="../terms.html">Terms of Use</a></li>
                    </ul>
                </div>
                <div class="footer-links">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="../conditions.html">Conditions</a></li>
                        <li><a href="../treatments.html">Treatments</a></li>
                        <li><a href="../glossary.html">Glossary</a></li>
                        <li><a href="../faq.html">FAQ</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p class="disclaimer">The information provided on ChronicSoreness is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment.</p>
                <p class="copyright">&copy; 2024 ChronicSoreness. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../js/main.js"></script>
</body>
</html>
